Prescription drug Published: RCT evidence Established use

Vaginal estradiol: dosing, timing and what to expect

Low-dose estradiol delivered directly to vaginal tissue for genitourinary syndrome of menopause. Sold as a 10 mcg tablet insert, a 4 or 10 mcg softgel, a 0.1 mg/g cream, or a ring releasing 7.5 mcg per 24 hours. Distinct from systemic estradiol in dose, schedule and risk profile.

Also known as Vagifem, Yuvafem, Imvexxy, Estring, Estrace cream, Oestrogel vaginal

Educational research reference TRT / HRT & Ancillary

Quick reference. Everything you need to run Vaginal estradiol — dosing, frequency, reconstitution math for the vial sizes people actually buy, and what it stacks with. For anything specific to your situation, ask the Guru.

Vaginal estradiol quick start

Route: Vaginal
Typical dose: 10 mcg insert, or 1 g of 0.1 mg/g cream
Frequency: Daily for 2 weeks, then twice weekly
Half-life: Local action; minimal systemic absorption at these doses.
Cycle: Continuous, with the loading-to-maintenance step at two weeks.

These are the numbers people actually run, drawn from the published record and from what the community has settled on over time. Educational reference, not medical advice — a starting point to work from, and one you can adjust as you learn how you respond.

How to run it

How often: Daily for 2 weeks, then twice weekly
Cycle length: Continuous, with the loading-to-maintenance step at two weeks.
Half-life: Local action; minimal systemic absorption at these doses.
Route: Vaginal

Consistency matters more than perfect timing. Pick a slot in your day you will actually keep, and let DoseIQ handle the rest.

For women

Nearly all products load daily for two weeks and then drop to twice weekly, three to four days apart — the spacing is part of the instruction, not a suggestion. Low-dose vaginal estrogen does not require a progestogen alongside it: the Menopause Society states opposition is not recommended, and the 2025 AUA/SUFU/AUGS guideline says clinicians should not perform endometrial surveillance for it. Note that Estring is local while Femring, which looks identical, is systemic and is a different product.

What to expect

Most people tolerate Vaginal estradiol well. Here is what is worth knowing going in, so nothing catches you by surprise.

Product labels are mid-change. FDA removed the boxed warnings for cardiovascular disease, breast cancer and probable dementia from estrogen-containing menopausal hormone therapy on 10 November 2025, and the rollout across individual products is staggered — the 2026 Estring label carries none while the 2025 Premarin vaginal cream label still carries all four. Read the leaflet in your own box rather than any summary, including this one.

Known interactions

Interactions involving Vaginal estradiol's drug class that DoseIQ screens for. Each one cites where it comes from — an FDA label section or the published record — because an interaction warning you can't trace is just noise.

Worth knowing Aromatase inhibitor + estrogen — working against each other

One suppresses estrogen while the other supplies it — pharmacologically contradictory unless very deliberately prescribed.

What to do: Worth confirming both are supposed to be running at once.

Source: Mechanism; anastrozole label

DoseIQ screens your whole protocol against these rules automatically — every compound, prescription and supplement you track, cross-checked as you add them. Serious flags are always free.

Preparing it

Vaginal estradiol does not need reconstituting — it comes ready to use. Nothing to reconstitute — supplied ready to use.

Track this in DoseIQ Browse all compounds

This page is an educational research reference and is not medical advice. Dose figures reflect the published record and what the community has converged on — starting points to weigh, not instructions. Consult a qualified healthcare provider before starting any protocol.